This is the final submission of the collaborative R01 MH094421 Psychiatric GWAS Consortium: Genomic Follow-Up Next-Gen Sequencing &Genotyping. The overall goal of this application is ambitious:
we aim to generate a trustworthy, high-confidence """"""""maps"""""""" of the genetic architecture of centrally important psychiatric diseases. Such maps consist of systematic and comprehensive evaluation of the allelic spectrum for these disorders including rare exonic, common SNP, and copy number variation. The feasibility of our aims is supported by the track record of the first iteration of the Psychiatric GWAS Consortium (""""""""PGC1"""""""") where we united nearly all major groups in the field into a harmonious and functional entity and completed our initial aims to a high scientific standard. Psychiatric diseases are compelling targets for intensive research: they are mostly idiopathic, first-rank public health problems, and cause enormous morbidity, mortality, and personal/societal cost. Consistent with the NIH mission, our goal is to elucidate fundamental knowledge of these diseases. In this """"""""PGC2"""""""" application, we propose to capitalize on prior NIH investments and on the success of PGC1 for the next logical set of aims. The PGC2 aims are """"""""large-scale"""""""" (largest sample sizes ever in the field) and """"""""comprehensive"""""""" (via the careful application of multiple genomic-scale technologies). Our focus is comprehensive in other senses - the PGC encompasses nearly the entire field, and we aim to elucidate the allelic spectrum of these disorders by integrating empirical data for all readily measurable types of genetic variation of etiological relevance (common SNP, rare exonic, and rare and common copy number variation - what we term the """"""""map""""""""). There are three analytic aims - systematically to assess copy number variation, to create a pipeline for the analysis of exome data (and eventually whole-genome data), and to investigate genetic associations that span traditional disease boundaries. Finally, we propose to develop the """"""""PsychChip"""""""" a custom 20,000 probe array targeting common SNP, exonic, and CNVs that would then be used to genotype 115,082 subjects. The PGC2 impact is potentially very large - a fundamental understanding of the genetics of these diseases would be a major milestone in psychiatry and in biomedicine.

Public Health Relevance

Psychiatric disorders cause enormous human suffering and cost to society. Our goal is rapidly to learn more about the genetics of some of these disorders. We propose to do this via the largest consortium ever constructed in the field, and by the use of several genetic technologies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01MH094432-02S1
Application #
8663986
Study Section
Special Emphasis Panel (ZRG1-PSE-M (03))
Program Officer
Addington, Anjene M
Project Start
2012-05-10
Project End
2016-03-31
Budget Start
2013-06-01
Budget End
2014-03-31
Support Year
2
Fiscal Year
2013
Total Cost
$109,996
Indirect Cost
$18,500
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
St Pourcain, B; Robinson, E B; Anttila, V et al. (2018) ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry 23:263-270
Duncan, L E; Ratanatharathorn, A; Aiello, A E et al. (2018) Largest GWAS of PTSD (N=20?070) yields genetic overlap with schizophrenia and sex differences in heritability. Mol Psychiatry 23:666-673
Brainstorm Consortium (see original citation for additional authors) (2018) Analysis of shared heritability in common disorders of the brain. Science 360:
Martin, Alicia R; Gignoux, Christopher R; Walters, Raymond K et al. (2017) Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations. Am J Hum Genet 100:635-649
Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium (2017) Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol Autism 8:21
Duncan, Laramie; Yilmaz, Zeynep; Gaspar, Helena et al. (2017) Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa. Am J Psychiatry 174:850-858
Weiner, Daniel J; Wigdor, Emilie M; Ripke, Stephan et al. (2017) Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nat Genet 49:978-985
Germine, L; Robinson, E B; Smoller, J W et al. (2016) Association between polygenic risk for schizophrenia, neurocognition and social cognition across development. Transl Psychiatry 6:e924
Lek, Monkol; Karczewski, Konrad J; Minikel, Eric V et al. (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285-91
Robinson, Elise B; St Pourcain, Beate; Anttila, Verneri et al. (2016) Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat Genet 48:552-5

Showing the most recent 10 out of 16 publications